nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—sympathetic nervous system—metabolic syndrome X	0.0753	0.202	CbGeAlD
Loperamide—POMC—brown adipose tissue—metabolic syndrome X	0.0651	0.175	CbGeAlD
Loperamide—POMC—autonomic nervous system—metabolic syndrome X	0.0506	0.136	CbGeAlD
Loperamide—Distention—Metformin—metabolic syndrome X	0.0325	0.275	CcSEcCtD
Loperamide—POMC—blood vessel—metabolic syndrome X	0.0224	0.06	CbGeAlD
Loperamide—CALM1—sympathetic nervous system—metabolic syndrome X	0.0205	0.0549	CbGeAlD
Loperamide—Abdominal bloating—Metformin—metabolic syndrome X	0.0161	0.136	CcSEcCtD
Loperamide—CALM1—autonomic nervous system—metabolic syndrome X	0.0138	0.0369	CbGeAlD
Loperamide—POMC—cardiovascular system—metabolic syndrome X	0.00997	0.0268	CbGeAlD
Loperamide—POMC—kidney—metabolic syndrome X	0.00976	0.0262	CbGeAlD
Loperamide—POMC—adipose tissue—metabolic syndrome X	0.00879	0.0236	CbGeAlD
Loperamide—CALM2—artery—metabolic syndrome X	0.00784	0.021	CbGeAlD
Loperamide—CALM1—artery—metabolic syndrome X	0.0078	0.0209	CbGeAlD
Loperamide—CALM2—endothelium—metabolic syndrome X	0.00662	0.0178	CbGeAlD
Loperamide—CALM1—endothelium—metabolic syndrome X	0.00659	0.0177	CbGeAlD
Loperamide—POMC—liver—metabolic syndrome X	0.00617	0.0165	CbGeAlD
Loperamide—CALM2—blood vessel—metabolic syndrome X	0.00611	0.0164	CbGeAlD
Loperamide—CALM1—blood vessel—metabolic syndrome X	0.00608	0.0163	CbGeAlD
Loperamide—OPRD1—kidney—metabolic syndrome X	0.00538	0.0144	CbGeAlD
Loperamide—Abdominal pain upper—Metformin—metabolic syndrome X	0.00508	0.043	CcSEcCtD
Loperamide—Abdominal distension—Metformin—metabolic syndrome X	0.00484	0.041	CcSEcCtD
Loperamide—Drowsiness—Metformin—metabolic syndrome X	0.00428	0.0363	CcSEcCtD
Loperamide—Immune system disorder—Metformin—metabolic syndrome X	0.00347	0.0294	CcSEcCtD
Loperamide—Flatulence—Metformin—metabolic syndrome X	0.0033	0.028	CcSEcCtD
Loperamide—CALM3—adipose tissue—metabolic syndrome X	0.00306	0.00821	CbGeAlD
Loperamide—Loss of consciousness—Metformin—metabolic syndrome X	0.00294	0.0249	CcSEcCtD
Loperamide—Tamoxifen—FMO3—metabolic syndrome X	0.0029	1	CrCbGaD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00283	0.024	CcSEcCtD
Loperamide—Discomfort—Metformin—metabolic syndrome X	0.00282	0.0239	CcSEcCtD
Loperamide—CALM2—cardiovascular system—metabolic syndrome X	0.00272	0.00731	CbGeAlD
Loperamide—CALM1—cardiovascular system—metabolic syndrome X	0.00271	0.00727	CbGeAlD
Loperamide—Nervous system disorder—Metformin—metabolic syndrome X	0.00268	0.0227	CcSEcCtD
Loperamide—CALM2—kidney—metabolic syndrome X	0.00266	0.00715	CbGeAlD
Loperamide—Skin disorder—Metformin—metabolic syndrome X	0.00265	0.0225	CcSEcCtD
Loperamide—CALM1—kidney—metabolic syndrome X	0.00265	0.00712	CbGeAlD
Loperamide—Somnolence—Metformin—metabolic syndrome X	0.00243	0.0206	CcSEcCtD
Loperamide—ABCB1—blood vessel—metabolic syndrome X	0.00243	0.00651	CbGeAlD
Loperamide—Dyspepsia—Metformin—metabolic syndrome X	0.0024	0.0204	CcSEcCtD
Loperamide—CALM2—adipose tissue—metabolic syndrome X	0.0024	0.00644	CbGeAlD
Loperamide—CALM1—adipose tissue—metabolic syndrome X	0.00239	0.00641	CbGeAlD
Loperamide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00236	0.02	CcSEcCtD
Loperamide—Fatigue—Metformin—metabolic syndrome X	0.00236	0.02	CcSEcCtD
Loperamide—Constipation—Metformin—metabolic syndrome X	0.00234	0.0198	CcSEcCtD
Loperamide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00223	0.0189	CcSEcCtD
Loperamide—CYP2C8—kidney—metabolic syndrome X	0.00221	0.00593	CbGeAlD
Loperamide—Urticaria—Metformin—metabolic syndrome X	0.00217	0.0184	CcSEcCtD
Loperamide—Abdominal pain—Metformin—metabolic syndrome X	0.00216	0.0183	CcSEcCtD
Loperamide—CALM3—liver—metabolic syndrome X	0.00214	0.00575	CbGeAlD
Loperamide—CYP2B6—cardiovascular system—metabolic syndrome X	0.00202	0.00543	CbGeAlD
Loperamide—CYP2B6—kidney—metabolic syndrome X	0.00198	0.00532	CbGeAlD
Loperamide—Asthenia—Metformin—metabolic syndrome X	0.00196	0.0166	CcSEcCtD
Loperamide—Pruritus—Metformin—metabolic syndrome X	0.00193	0.0164	CcSEcCtD
Loperamide—Diarrhoea—Metformin—metabolic syndrome X	0.00187	0.0158	CcSEcCtD
Loperamide—Dizziness—Metformin—metabolic syndrome X	0.00181	0.0153	CcSEcCtD
Loperamide—Vomiting—Metformin—metabolic syndrome X	0.00174	0.0147	CcSEcCtD
Loperamide—Rash—Metformin—metabolic syndrome X	0.00172	0.0146	CcSEcCtD
Loperamide—Dermatitis—Metformin—metabolic syndrome X	0.00172	0.0146	CcSEcCtD
Loperamide—Headache—Metformin—metabolic syndrome X	0.00171	0.0145	CcSEcCtD
Loperamide—CALM2—liver—metabolic syndrome X	0.00168	0.00452	CbGeAlD
Loperamide—CALM1—liver—metabolic syndrome X	0.00168	0.0045	CbGeAlD
Loperamide—Nausea—Metformin—metabolic syndrome X	0.00162	0.0138	CcSEcCtD
Loperamide—CYP3A4—kidney—metabolic syndrome X	0.0015	0.00401	CbGeAlD
Loperamide—CYP2D6—kidney—metabolic syndrome X	0.00147	0.00395	CbGeAlD
Loperamide—CYP2C8—liver—metabolic syndrome X	0.0014	0.00375	CbGeAlD
Loperamide—CYP2B6—liver—metabolic syndrome X	0.00125	0.00336	CbGeAlD
Loperamide—ABCB1—cardiovascular system—metabolic syndrome X	0.00108	0.0029	CbGeAlD
Loperamide—ABCB1—kidney—metabolic syndrome X	0.00106	0.00284	CbGeAlD
Loperamide—ABCB1—adipose tissue—metabolic syndrome X	0.000954	0.00256	CbGeAlD
Loperamide—CYP3A4—liver—metabolic syndrome X	0.000946	0.00254	CbGeAlD
Loperamide—CYP2D6—liver—metabolic syndrome X	0.00093	0.0025	CbGeAlD
Loperamide—ABCB1—liver—metabolic syndrome X	0.000669	0.0018	CbGeAlD
Loperamide—CALM1—Signaling by GPCR—CCL2—metabolic syndrome X	3.21e-05	6.35e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GCKR—metabolic syndrome X	3.21e-05	6.34e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LPA—metabolic syndrome X	3.21e-05	6.34e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—APOA1—metabolic syndrome X	3.19e-05	6.3e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—APOA1—metabolic syndrome X	3.19e-05	6.3e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCL2—metabolic syndrome X	3.17e-05	6.26e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CD36—metabolic syndrome X	3.17e-05	6.25e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IGF1—metabolic syndrome X	3.12e-05	6.16e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IRS1—metabolic syndrome X	3.12e-05	6.16e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IRS1—metabolic syndrome X	3.12e-05	6.16e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GOT1—metabolic syndrome X	3.12e-05	6.15e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GGT1—metabolic syndrome X	3.12e-05	6.15e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	3.11e-05	6.14e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA5—metabolic syndrome X	3.08e-05	6.08e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CD36—metabolic syndrome X	3.06e-05	6.05e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CD36—metabolic syndrome X	3.06e-05	6.05e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOB—metabolic syndrome X	3.04e-05	5.99e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	3.03e-05	5.99e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	3.03e-05	5.99e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PPARA—metabolic syndrome X	3.02e-05	5.97e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF2—metabolic syndrome X	3.01e-05	5.94e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IRS1—metabolic syndrome X	2.98e-05	5.87e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AKT1—metabolic syndrome X	2.97e-05	5.86e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	2.96e-05	5.85e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	2.95e-05	5.83e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PPARA—metabolic syndrome X	2.94e-05	5.81e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GGT1—metabolic syndrome X	2.94e-05	5.8e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GOT1—metabolic syndrome X	2.94e-05	5.8e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AGT—metabolic syndrome X	2.93e-05	5.78e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOB—metabolic syndrome X	2.92e-05	5.76e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF2—metabolic syndrome X	2.91e-05	5.74e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF2—metabolic syndrome X	2.91e-05	5.74e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—LPL—metabolic syndrome X	2.9e-05	5.72e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IRS1—metabolic syndrome X	2.88e-05	5.68e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IRS1—metabolic syndrome X	2.88e-05	5.68e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—metabolic syndrome X	2.87e-05	5.67e-05	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—metabolic syndrome X	2.87e-05	5.66e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.86e-05	5.65e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AGT—metabolic syndrome X	2.85e-05	5.63e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL5—metabolic syndrome X	2.85e-05	5.63e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—INS—metabolic syndrome X	2.85e-05	5.63e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PPARA—metabolic syndrome X	2.85e-05	5.62e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PPARA—metabolic syndrome X	2.85e-05	5.62e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.84e-05	5.61e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOA1—metabolic syndrome X	2.84e-05	5.6e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—metabolic syndrome X	2.83e-05	5.58e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOB—metabolic syndrome X	2.82e-05	5.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOB—metabolic syndrome X	2.82e-05	5.57e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—metabolic syndrome X	2.82e-05	5.57e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—metabolic syndrome X	2.79e-05	5.52e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LPL—metabolic syndrome X	2.79e-05	5.5e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOA1—metabolic syndrome X	2.76e-05	5.45e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AGT—metabolic syndrome X	2.76e-05	5.45e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AGT—metabolic syndrome X	2.76e-05	5.45e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL5—metabolic syndrome X	2.76e-05	5.44e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL5—metabolic syndrome X	2.76e-05	5.44e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—INS—metabolic syndrome X	2.76e-05	5.44e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—INS—metabolic syndrome X	2.76e-05	5.44e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CD36—metabolic syndrome X	2.75e-05	5.44e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.75e-05	5.42e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.75e-05	5.42e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—metabolic syndrome X	2.7e-05	5.34e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—metabolic syndrome X	2.7e-05	5.34e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LPL—metabolic syndrome X	2.7e-05	5.32e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LPL—metabolic syndrome X	2.7e-05	5.32e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOA1—metabolic syndrome X	2.67e-05	5.27e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOA1—metabolic syndrome X	2.67e-05	5.27e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOB—metabolic syndrome X	2.64e-05	5.22e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—SERPINE1—metabolic syndrome X	2.62e-05	5.17e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—metabolic syndrome X	2.6e-05	5.14e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	2.57e-05	5.08e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.57e-05	5.07e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARA—metabolic syndrome X	2.56e-05	5.06e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.55e-05	5.03e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.55e-05	5.03e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.53e-05	5e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—SERPINE1—metabolic syndrome X	2.53e-05	5e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—SERPINE1—metabolic syndrome X	2.53e-05	5e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—LPL—metabolic syndrome X	2.53e-05	4.99e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—metabolic syndrome X	2.52e-05	4.98e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PPARG—metabolic syndrome X	2.5e-05	4.94e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—metabolic syndrome X	2.5e-05	4.93e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOB—metabolic syndrome X	2.49e-05	4.92e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AGT—metabolic syndrome X	2.48e-05	4.9e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.46e-05	4.86e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—INS—metabolic syndrome X	2.45e-05	4.84e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PPARG—metabolic syndrome X	2.43e-05	4.8e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—metabolic syndrome X	2.43e-05	4.8e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	2.42e-05	4.79e-05	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	2.42e-05	4.78e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—metabolic syndrome X	2.42e-05	4.77e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—metabolic syndrome X	2.42e-05	4.77e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOA1—metabolic syndrome X	2.4e-05	4.74e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CD36—metabolic syndrome X	2.4e-05	4.74e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—INS—metabolic syndrome X	2.39e-05	4.71e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—metabolic syndrome X	2.38e-05	4.71e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGT—metabolic syndrome X	2.38e-05	4.71e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—LPL—metabolic syndrome X	2.38e-05	4.7e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—metabolic syndrome X	2.37e-05	4.68e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.36e-05	4.65e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PPARG—metabolic syndrome X	2.35e-05	4.65e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PPARG—metabolic syndrome X	2.35e-05	4.65e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEP—metabolic syndrome X	2.34e-05	4.61e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—metabolic syndrome X	2.34e-05	4.61e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—metabolic syndrome X	2.32e-05	4.57e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOA1—metabolic syndrome X	2.31e-05	4.56e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—INS—metabolic syndrome X	2.31e-05	4.56e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—INS—metabolic syndrome X	2.31e-05	4.56e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGT—metabolic syndrome X	2.31e-05	4.55e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGT—metabolic syndrome X	2.31e-05	4.55e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—metabolic syndrome X	2.29e-05	4.53e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—metabolic syndrome X	2.29e-05	4.53e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	2.29e-05	4.52e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—metabolic syndrome X	2.29e-05	4.51e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CD36—metabolic syndrome X	2.26e-05	4.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—metabolic syndrome X	2.26e-05	4.46e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—metabolic syndrome X	2.26e-05	4.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—metabolic syndrome X	2.26e-05	4.46e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—metabolic syndrome X	2.26e-05	4.46e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—metabolic syndrome X	2.25e-05	4.44e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—metabolic syndrome X	2.24e-05	4.42e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—metabolic syndrome X	2.24e-05	4.42e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOA1—metabolic syndrome X	2.23e-05	4.41e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOA1—metabolic syndrome X	2.23e-05	4.41e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARA—metabolic syndrome X	2.23e-05	4.4e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	2.22e-05	4.39e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GOT2—metabolic syndrome X	2.22e-05	4.39e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—metabolic syndrome X	2.21e-05	4.37e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—metabolic syndrome X	2.21e-05	4.37e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—metabolic syndrome X	2.21e-05	4.37e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—metabolic syndrome X	2.2e-05	4.34e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—metabolic syndrome X	2.19e-05	4.32e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AGT—metabolic syndrome X	2.16e-05	4.27e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—metabolic syndrome X	2.15e-05	4.25e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—metabolic syndrome X	2.14e-05	4.22e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—metabolic syndrome X	2.12e-05	4.18e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARG—metabolic syndrome X	2.12e-05	4.18e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—metabolic syndrome X	2.12e-05	4.18e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—metabolic syndrome X	2.12e-05	4.18e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARA—metabolic syndrome X	2.1e-05	4.15e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—metabolic syndrome X	2.09e-05	4.13e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOA1—metabolic syndrome X	2.09e-05	4.13e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IRS1—metabolic syndrome X	2.08e-05	4.11e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—INS—metabolic syndrome X	2.08e-05	4.1e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—metabolic syndrome X	2.07e-05	4.08e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—metabolic syndrome X	2.07e-05	4.08e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—metabolic syndrome X	2.05e-05	4.05e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AGT—metabolic syndrome X	2.04e-05	4.02e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—metabolic syndrome X	2.02e-05	4e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—metabolic syndrome X	2.02e-05	4e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IRS1—metabolic syndrome X	2.02e-05	3.98e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IRS1—metabolic syndrome X	2.02e-05	3.98e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—INS—metabolic syndrome X	2e-05	3.94e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.99e-05	3.94e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—metabolic syndrome X	1.98e-05	3.92e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—metabolic syndrome X	1.98e-05	3.92e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.98e-05	3.92e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.98e-05	3.92e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOA1—metabolic syndrome X	1.97e-05	3.89e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—metabolic syndrome X	1.97e-05	3.88e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—metabolic syndrome X	1.96e-05	3.88e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—INS—metabolic syndrome X	1.93e-05	3.81e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—INS—metabolic syndrome X	1.93e-05	3.81e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—metabolic syndrome X	1.93e-05	3.81e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.92e-05	3.79e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.92e-05	3.79e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—metabolic syndrome X	1.91e-05	3.78e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—metabolic syndrome X	1.9e-05	3.76e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—metabolic syndrome X	1.9e-05	3.75e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—metabolic syndrome X	1.9e-05	3.75e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—metabolic syndrome X	1.9e-05	3.75e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—metabolic syndrome X	1.87e-05	3.69e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—metabolic syndrome X	1.87e-05	3.69e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—metabolic syndrome X	1.87e-05	3.69e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—metabolic syndrome X	1.85e-05	3.66e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—metabolic syndrome X	1.85e-05	3.66e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.84e-05	3.64e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.83e-05	3.62e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—metabolic syndrome X	1.82e-05	3.59e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—INS—metabolic syndrome X	1.81e-05	3.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.77e-05	3.5e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.77e-05	3.5e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—metabolic syndrome X	1.75e-05	3.46e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—metabolic syndrome X	1.75e-05	3.45e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.74e-05	3.43e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—INS—metabolic syndrome X	1.7e-05	3.36e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—metabolic syndrome X	1.69e-05	3.34e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—metabolic syndrome X	1.69e-05	3.34e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—metabolic syndrome X	1.67e-05	3.29e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	1.66e-05	3.29e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—metabolic syndrome X	1.66e-05	3.27e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—metabolic syndrome X	1.65e-05	3.26e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.63e-05	3.22e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—metabolic syndrome X	1.6e-05	3.16e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—metabolic syndrome X	1.6e-05	3.16e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.59e-05	3.13e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.58e-05	3.13e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—metabolic syndrome X	1.56e-05	3.08e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.56e-05	3.07e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—metabolic syndrome X	1.54e-05	3.04e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—metabolic syndrome X	1.49e-05	2.95e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.48e-05	2.92e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—metabolic syndrome X	1.48e-05	2.91e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.45e-05	2.86e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—metabolic syndrome X	1.43e-05	2.82e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—metabolic syndrome X	1.43e-05	2.82e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—metabolic syndrome X	1.41e-05	2.78e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.37e-05	2.71e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	1.37e-05	2.7e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—metabolic syndrome X	1.36e-05	2.69e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—metabolic syndrome X	1.35e-05	2.66e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.33e-05	2.63e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—metabolic syndrome X	1.32e-05	2.6e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—metabolic syndrome X	1.32e-05	2.6e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—metabolic syndrome X	1.3e-05	2.58e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—metabolic syndrome X	1.3e-05	2.58e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.3e-05	2.58e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—metabolic syndrome X	1.3e-05	2.57e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.29e-05	2.55e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—metabolic syndrome X	1.24e-05	2.46e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—metabolic syndrome X	1.24e-05	2.46e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—metabolic syndrome X	1.2e-05	2.38e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—metabolic syndrome X	1.2e-05	2.38e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—metabolic syndrome X	1.2e-05	2.38e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—metabolic syndrome X	1.2e-05	2.38e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—metabolic syndrome X	1.16e-05	2.28e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—metabolic syndrome X	1.15e-05	2.27e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.14e-05	2.24e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—metabolic syndrome X	1.12e-05	2.21e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—metabolic syndrome X	1.12e-05	2.21e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—INS—metabolic syndrome X	1.11e-05	2.2e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—metabolic syndrome X	1.11e-05	2.19e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—metabolic syndrome X	1.11e-05	2.19e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.02e-05	2.02e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—metabolic syndrome X	9.88e-06	1.95e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—metabolic syndrome X	9.77e-06	1.93e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—metabolic syndrome X	9.62e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—metabolic syndrome X	9.3e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—metabolic syndrome X	9.3e-06	1.84e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	8.94e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—metabolic syndrome X	8.72e-06	1.72e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—metabolic syndrome X	8.43e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—metabolic syndrome X	8.43e-06	1.67e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—metabolic syndrome X	8.37e-06	1.65e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—metabolic syndrome X	8.04e-06	1.59e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—metabolic syndrome X	7.78e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—metabolic syndrome X	7.78e-06	1.54e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—metabolic syndrome X	7.29e-06	1.44e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—metabolic syndrome X	6.87e-06	1.36e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—metabolic syndrome X	4.49e-06	8.87e-06	CbGpPWpGaD
